Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage (PPH)

Kanuni Sultan Suleyman Training and Research Hospital

Status: Completed

Conditions: Post Partum Hemorrhage; Anti-Mullerian Hormone Deficiency

Treatments: Other: anti- mullerian hormone

Study type: Observational

Funder types: Other

Identifiers

NCT03907605

amhpph

Details and patient eligibility

About

Anti-Mullerian hormone (AMH) is a marker for ovarian reserve. There are many studies about AMH changes in ovarian surgery, but little is known for other surgeries. We seek to investigate the hormone variations before and after uterine artey ligation for postpartum hemorrage (PPH)

Full description

All patients belong to the same group. The blood samples will be collected at the time of surgery and 3 months after surgery from the patients who need uterine artery ligation for PPH. The blood samples will be centrifuged within 2 hours after being obtained and assessed on the same day. AMH concentrations will be measured with an enzymatically amplified two-sided immunoassay

Enrollment: 88 patients

Sex: Female

Ages: 18 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• age 18- 40 years
• no systemic or endocrine diseases
• patients who had uterine artery ligation due to PPH

Exclusion criteria

• Pregnancy with IVF or oosit donation
• Patients with endocrinopathy, diseases which require radiotherapy and chemotherapy etc.
• Patients with BMI >40